Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to $1.3 million.

  • Ekso Bionics Holdings' Other Operating Expenses fell 2539.77% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year decrease of 1097.61%. This contributed to the annual value of $7.3 million for FY2024, which is 13948.99% up from last year.
  • Per Ekso Bionics Holdings' latest filing, its Other Operating Expenses stood at $1.3 million for Q3 2025, which was down 2539.77% from $1.7 million recorded in Q2 2025.
  • Over the past 5 years, Ekso Bionics Holdings' Other Operating Expenses peaked at $2.3 million during Q2 2023, and registered a low of $1.3 million during Q3 2025.
  • Its 5-year average for Other Operating Expenses is $1.8 million, with a median of $1.8 million in 2024.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first plummeted by 2884.92% in 2021, then soared by 2817.68% in 2023.
  • Ekso Bionics Holdings' Other Operating Expenses (Quarter) stood at $2.0 million in 2021, then fell by 4.66% to $1.9 million in 2022, then rose by 1.95% to $2.0 million in 2023, then dropped by 4.99% to $1.9 million in 2024, then tumbled by 30.31% to $1.3 million in 2025.
  • Its Other Operating Expenses stands at $1.3 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.7 million for Q1 2025.